Company Filing History:
Years Active: 2016
Title: The Innovations of Mingfu Liu
Introduction
Mingfu Liu is a prominent inventor based in Carson, CA (US). He has made significant contributions to the field of immunotherapy and fungal disease diagnosis. With a total of 2 patents, his work focuses on innovative solutions for combating serious health conditions.
Latest Patents
Mingfu Liu's latest patents include groundbreaking inventions aimed at diagnosing and treating mucormycosis. The first patent, titled "Immunotherapy and diagnosis of mucormycosis using CotH," provides Mucorales CotH polypeptides and encoding nucleic acid molecules. These innovations can be effectively utilized to diagnose, treat, or prevent fungal conditions, particularly mucormycosis. The second patent, "Mammalian receptors as targets for antibody and active vaccination therapy against mold infections," offers therapeutic compositions and methods for treating and preventing fungal diseases, including mucormycosis. This invention includes antibody, antibody fragment, siRNA, and vaccine compositions directed against a GRP78 polypeptide or an antigenic fragment of the polypeptide.
Career Highlights
Mingfu Liu is affiliated with the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. His work at this esteemed institution has allowed him to focus on critical research in the field of fungal infections and immunotherapy.
Collaborations
Mingfu Liu has collaborated with notable colleagues, including Ashraf S Ibrahim and Yue Fu. Their combined expertise contributes to the advancement of research in their respective fields.
Conclusion
Mingfu Liu's innovative work in immunotherapy and fungal disease diagnosis showcases his dedication to improving health outcomes. His patents reflect a commitment to addressing significant medical challenges through scientific research and collaboration.